Correlation Between Unicycive Therapeutics and OncoSec Medical

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and OncoSec Medical, you can compare the effects of market volatilities on Unicycive Therapeutics and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and OncoSec Medical.

Diversification Opportunities for Unicycive Therapeutics and OncoSec Medical

-0.76

Correlation Coefficient

Unicycive Therapeutics  OncoSec Medical

Pay attention - limited upside

The 3 months correlation between Unicycive and OncoSec is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and OncoSec Medical go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and OncoSec Medical

If you would invest  32.00  in Unicycive Therapeutics on September 2, 2024 and sell it today you would earn a total of  37.00  from holding Unicycive Therapeutics or generate 115.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	1.56%
Values	Daily Returns

Unicycive Therapeutics  vs.  OncoSec Medical

Unicycive Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

OncoSec Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Unicycive Therapeutics and OncoSec Medical

The main advantage of trading using opposite Unicycive Therapeutics and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.

The idea behind Unicycive Therapeutics and OncoSec Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.